HR 6867

The NIH Clinical Trial Integrity Act aims to increase diversity in clinical trials by requiring sponsors to establish clear goals for recruiting participants from various racial, ethnic, age, and sex groups. It mandates detailed plans for achieving these goals, including strategies for enrollment and retention, and encourages the use of flexible follow-up methods. The bill also promotes education for researchers and reviewers on diversity in clinical trials, establishes a system for sharing trial data, and seeks to eliminate barriers to participation, such as cost and regulatory hurdles. Finally, it directs a study on existing efforts to address barriers to clinical trial participation and proposes a public awareness campaign to encourage diverse participation.